| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 2,690,000 | 2,754,000 | 2,455,000 | 2,517,000 | | Cost of Revenue | 824,000 | 864,000 | 738,000 | 755,000 | | | Gross Profit | 1,866,000 | 1,890,000 | 1,717,000 | 1,762,000 | | | Operating Expenses | | Research Development | 614,000 | 619,000 | 603,000 | 604,000 | | Selling General and Administrative | 621,000 | 376,000 | 376,000 | 413,000 | | Non Recurring | 35,000 |
-
| 748,000 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 596,000 | 895,000 | (10,000) | 745,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 146,000 | 89,000 | (91,000) | (294,000) | | Earnings Before Interest And Taxes | 742,000 | 984,000 | (101,000) | 451,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 742,000 | 984,000 | (101,000) | 451,000 | | Income Tax Expense | (60,000) | 246,000 | 188,000 | 110,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 802,000 | 738,000 | (289,000) | 341,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 802,000 | 738,000 | (289,000) | 341,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $802,000 | $738,000 | ($289,000) | $341,000 |
|
0.20% Nasdaq 
Income Statement
